Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

标题
Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
作者
关键词
metastatic colorectal carcinoma, cancer treatment, biomarkers, Src kinase, pdx models
出版物
Oncotarget
Volume 7, Issue 22, Pages -
出版商
Impact Journals, LLC
发表日期
2016-04-21
DOI
10.18632/oncotarget.8880

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started